Diagnostic pathology in the era of molecular targeted therapy

نویسندگان

چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Cytoreductive surgery in the era of targeted molecular therapy

Cytoreductive nephrectomy (CN) was regarded standard of care for patients with metastatic renal cell carcinoma (mRCC) in the immunotherapy era. With the advent of targeted molecular therapy (TMT) for the treatment of mRCC, the routine use of CN has been questioned. Up to date evidence continues to suggest that CN remains an integral part of treatment in appropriately selected patients. This rev...

متن کامل

Targeted antimicrobial therapy in the microbiome era

Even though the oral microbiome is one of the most complex sites on the body it is an excellent model for narrow-spectrum antimicrobial therapy. Current research indicates that disruption of the microbiome leads to a dysbiotic environment allowing for the overgrowth of pathogenic species and the onset of oral diseases. The gram-negative colonizer, Porphyromonas gingivalis has long been consider...

متن کامل

Role of Pathology and Immunohistochemistry in the New Era Of Molecular Therapy

The modern practice of pathology entails increasing involvement with management of cancer patients. Pathologists are often faced with clinical and research involvements that obligate them to search for prognostic and therapeutic markers on patients’ tumor samples. A practical example would be the detection of HER2-neu in breast cancer which has revolutionized the use of prognostic-therapeutic i...

متن کامل

Chronic myeloid leukemia therapy in the era of tyrosine kinase inhibitors. The first molecular targeted treatment

Chronic Myeloid Leukemia is the first malignant disorder with a specific genetic abnormality in the background. Known as a disease with an inexorable progression to acute leukemia for many years, its natural history has been dramatically improved by the use of tyrosine kinase inhibitors (TKI). They represent the first molecular targeted therapy addressed to a neoplastic disorder. From these new...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Tenri Medical Bulletin

سال: 2012

ISSN: 1344-1817,2187-2244

DOI: 10.12936/tenrikiyo.18-011